Cat#:FCGR3B-008HAC;Product Name:Recombinant Human FCGR3B (NA2) Protein;Synonym:FCGR3B; FCR-10; FCRIII; FCRIIIb; CD16; FCG3; CD16b; FCGR3;;Description:Recombinant Human FCGR3B / CD16b fused with His Tag is produced in HEK293 cells. It contains AA Gly 17 - Ser 200. The NA2 form of the CD16B differ with the NA1 form of CD16B in AA36, 65, 82, and 106. The NA2 form carries S36, S65, N82, and I106, while the NA1 form carries R36, N65, D82, and V106.;Source:HEK293;Predicted N Terminal:Gly 17;Molecular Characterization:This recombinant human FCGR3B protein carries a His tag at the C terminus. The human FCGR3B protein has a calculated molecular weight of 22.7 kDa. The human FCGR3B protein migrates as 38-50 kDa under reducing R condition SDS-PAGE due to glycosylation.;Purity:Greater than 95% as determined by SDS-PAGE.;Endotoxin:< 1.0 EU per ug of human FCGR3B protein by the LAL method.;Formulation:Recombinant human FCGR3B (NA2) protein was lyophilized from 0.22 um filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.;Stability:Recombinant human FCGR3B (NA2) protein was stable up to 1 year from date of receipt at -70℃;Storage:Store recombinant human FCGR3B (NA2) protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.;Usage:For Lab Research Use Only;
Recombinant Human FCGR3B / CD16b fused with His Tag is produced in HEK293 cells. It contains AA Gly 17 - Ser 200. The NA2 form of the CD16B differ with the NA1 form of CD16B in AA36, 65, 82, and 106. The NA2 form carries S36, S65, N82, and I106, while the NA1 form carries R36, N65, D82, and V106.
Source:
HEK293
Predicted N Terminal:
Gly 17
Molecular Characterization:
This recombinant human FCGR3B protein carries a His tag at the C terminus. The human FCGR3B protein has a calculated molecular weight of 22.7 kDa. The human FCGR3B protein migrates as 38-50 kDa under reducing R condition SDS-PAGE due to glycosylation.
Purity:
Greater than 95% as determined by SDS-PAGE.
Endotoxin:
< 1.0 EU per ug of human FCGR3B protein by the LAL method.
Formulation:
Recombinant human FCGR3B (NA2) protein was lyophilized from 0.22 um filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
Stability:
Recombinant human FCGR3B (NA2) protein was stable up to 1 year from date of receipt at -70℃
Usage:
For Lab Research Use Only
Storage:
Store recombinant human FCGR3B (NA2) protein under sterile conditions at -20℃ to -80℃. It is recommended that the recombinant protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.